N/A N=843 Randomized Screening

Perinatal mHealth Intervention in Guatemala

Pregnancy · Prenatal Care

Bottom Line

View on ClinicalTrials.gov: NCT02348840 ↗

Enrolled (actual)

843

Serious AEs

0.0%

Results posted

Aug 2019

Primary outcome: Primary: Referral Rates to Local Hospitals — 33; 20; 31; 34 Referrals per 100 births

Study Design & Population

Study type: Interventional
Phase: N/A
Interventions: mHealth (Device)
Age: Adult, Older Adult · 18+ yrs
Sex: All
Sponsor: Emory University
Primary completion: Feb 2018

Outcome Measures

Outcome	Result	p-value
PRIMARY Referral Rates to Local Hospitals	33; 20; 31; 34	—
PRIMARY Number of Neonatal Deaths	7; 3	—
SECONDARY Successful Referrals	69; 44; 48; 47	—

Summary

The purpose of the study is to explore ways to improve maternal and child outcomes in the ethnic Maya speaking the Kaqchikel language population, which experiences wide disparities in health care access and outcomes when compared to other inhabitants of Guatemala who are not ethnically Maya and live in other parts of the country.

Eligibility Criteria

Inclusion Criteria for Midwives:

Wuqu' Kawoq's catchment area
Bilingual speakers of Spanish and Kaqchikel Maya
Willing to give consent and be trained on the mHealth technology
Must be under the age of 65
Must be 18 years-old or older

Exclusion Criteria for Midwives:

Outside Wuqu' Kawoq's catchment area
Not a bilingual speaker of Spanish and Kaqchikel Maya
Over the age of 65
Under the age of 18
Unable to give consent and be trained on the mHealth technology

Inclusion Criteria for Pregnant Women:

Must be 18 years-old or older
Must be pregnant
Must have a midwife that has been recruited for the study
Bilingual speakers of Spanish and Kaqchikel Maya
Willing to give consent

Exclusion criteria for pregnant women

Under 18 years of age
Not pregnant
Does not have a midwife in the study
Is not bilingual in Spanish and Kaqchikel Maya
Unable to consent

View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT02348840). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.